B細胞非ホジキンリンパ腫:世界の臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
B-Cell Non-Hodgkin Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of B-Cell Non-Hodgkin Lymphoma 25
Subjects Recruited Over a Period of Time 37
Clinical Trials by Sponsor Type 38
Prominent Sponsors 39
Top Companies Participating in B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials 40
Prominent Drugs 42
Latest Clinical Trials News on B-Cell Non-Hodgkin Lymphoma 43
Dec 04, 2013: Completion of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma 43
Jun 17, 2013: Cell Therapeutics Announces Results From Sub-set Analyses Of Data From Phase III EXTEND Clinical Trial Of Pixuvri 43
May 06, 2013: Senesco Gets DRC Approval To Initiate Cohort 3 In Phase Ib/IIa Study In Multiple Myeloma And Non-Hodgkins B-Cell Lymphoma 44
Feb 11, 2013: TG Therapeutics Opens Expansion Cohorts In Phase I/II Trial Of TG-1101 In Patients With Rituximab Relapsed Or Refractory B-cell Non-Hodgkin’s Lymphoma 45
Feb 06, 2013: Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A 46
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Celgene Corporation 54
Clinical Trial Overview of Celgene Corporation 54
Takeda Pharmaceutical Company Limited 58
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 58
GlaxoSmithKline plc 61
Clinical Trial Overview of GlaxoSmithKline plc 61
Amgen Inc. 64
Clinical Trial Overview of Amgen Inc. 64
Novartis AG 67
Clinical Trial Overview of Novartis AG 67
Pharmacyclics, Inc. 70
Clinical Trial Overview of Pharmacyclics, Inc. 70
Pfizer Inc. 73
Clinical Trial Overview of Pfizer Inc. 73
Biogen Idec Inc. 76
Clinical Trial Overview of Biogen Idec Inc. 76
Immunomedics, Inc. 79
Clinical Trial Overview of Immunomedics, Inc. 79
Clinical Trial Overview of Top Institutes / Government 81
National Cancer Institute 81
Clinical Trial Overview of National Cancer Institute 81
Fred Hutchinson Cancer Research Center 92
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 92
The University of Texas M. D. Anderson Cancer Center 97
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 97
Memorial Sloan Kettering Cancer Center 100
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 100
Mayo Clinic 102
Clinical Trial Overview of Mayo Clinic 102
Southwest Oncology Group 104
Clinical Trial Overview of Southwest Oncology Group 104
Groupe d’Etudes de Lymphomes de L’Adulte 106
Clinical Trial Overview of Groupe d’Etudes de Lymphomes de L’Adulte 106
City of Hope National Medical Center 108
Clinical Trial Overview of City of Hope National Medical Center 108
Stanford University 110
Clinical Trial Overview of Stanford University 110
Five Key Clinical Profiles 111
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 203


【レポート販売概要】

■ タイトル:B細胞非ホジキンリンパ腫:世界の臨床試験レビュー(2014年上半期)
■ 英文:B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDHC2054CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。